<DOC>
	<DOCNO>NCT01392105</DOCNO>
	<brief_summary>Early reperfusion strategy tandem remarkable advance drug device treat myocardial infarction ( MI ) contribute reduction early mortality , cardiovascular disease remain leading cause death worldwide . Current management strategy solve problem cardiomyocyte loss consequent progression heart failure . In respect , stem-cell therapy show potential benefit repair damage myocardium . Mesenchymal stem cell ( MSCs ) consider attractive therapeutic candidate high capacity replication : paracrine effect : ability preserve potency : cause adverse reaction allogeneic versus autologous transplant . Intracoronary injection stem cell seem safe , one clinical trial use MSCs via intracoronary route set acute myocardial infarction ( AMI ) carry . The investigator therefore assessed safety efficacy intracoronary autologous bone marrow ( BM ) -derived human MSCs patient AMI .</brief_summary>
	<brief_title>Safety Efficacy Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>age 1870 year ischemic chest pain &gt; 30 min admit hospital &lt; 24 h onset chest pain electrocardiography show ST segment elevation &gt; 1 mm two consecutive lead limb lead &gt; 2 mm precordial lead could enrol study &lt; 72 h successful revascularization cardiogenic shock ( define systolic blood pressure &lt; 90 mmHg require intravenous pressor intraaortic balloon counterpulsation ) lifethreatening arrhythmia impossible condition cardiac catheterization advance renal hepatic dysfunction history previous coronary artery bypass graft history hematologic disease history malignancy major bleed require blood transfusion stroke transient ischemic attack previous 6 month structural abnormality central nervous system ( brain tumor , aneurysm , history surgery ) traumatic injury myocardial infarction use corticosteroid antibiotic previous month major surgical procedure previous 3 month cardiopulmonary resuscitation &gt; 10 min within previous 2 week positive skin test penicillin positive result viral marker ( human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) Venereal Disease Research Laboratory ( VDRL ) test ) pregnancy , possible candidate pregnancy breastfeed female drug abuser inappropriate patient participate study accord chief investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Left ventricular dysfunction</keyword>
</DOC>